Stocks and Investing
Stocks and Investing
Fri, May 10, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, May 9, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jacob Hughes Maintained (TEVA) at Hold with Decreased Target to $17 on, May 9th, 2019
Jacob Hughes of Wells Fargo, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Decreased Target from $18 to $17 on, May 9th, 2019.
Jacob has made no other calls on TEVA in the last 4 months.
There are 5 other peers that have a rating on TEVA. Out of the 5 peers that are also analyzing TEVA, 3 agree with Jacob's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Risinger of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $17 on, Wednesday, March 6th, 2019
- Vamil Divan of "Credit Suisse" Maintained at Hold with Decreased Target to $20 on, Thursday, February 14th, 2019
- David Amsellem of "Piper Sandler" Upgraded from Sell to Hold and Increased Target to $16 on, Wednesday, January 23rd, 2019
These are the ratings of the 2 analyists that currently disagree with Jacob
- Liav Abraham of "Citigroup" Maintained at Strong Buy with Decreased Target to $23 on, Thursday, April 11th, 2019
- Elliot Wilbur of "Raymond James" Upgraded from Hold to Buy on, Thursday, February 14th, 2019